AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Tenpoint Therapeutics raises $85M in Series B to accelerate commercialization of FDA-approved presbyopia treatment Yuvezzi.
PRIVATESep 24, 2026•about 3 hours ago
Amount Raised
$85 Million
Round Type
Series B
SeattleBiotechnologyHealth CareTherapeutics
Description
Tenpoint Therapeutics, a Warren, New Jersey-based biotech developing treatments for age-related vision conditions, announced an $85 million Series B funding round in January. The company also secured a $150 million nondilutive senior secured term loan facility with Hercules Capital, bringing total capital to $235 million. Tenpoint is using the combined funding to accelerate commercialization of Yuvezzi, its FDA-approved dual-agent eye drop for presbyopia, which became available nationwide in March. The company is actively hiring across multiple regions to support its commercial expansion.
Company Information
Company
Tenpoint Therapeutics
Location
Seattle, Washington, United States
About
Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. We are addressing the ultimate cause of vision loss by replacing diseased cells with healthy ones to permanently restore vision. Tenpoint’s global team is united by our passion for science and our commitment to patients.
Fundz sees it the moment Tenpoint Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SeattleBiotechnologyHealth CareTherapeutics